County of Van Zandt v. Purdue Pharma, L.P., et al
County of Van Zandt |
Purdue Pharma, L.P, JANSSEN PHARMACEUTICALS, INC., The Purdue Frederick Company Inc., Amerisourcebergen Corporation, Endo Pharmaceuticals, Inc., Purdue Pharma L. P., JANSSEN PHARMACEUTICA INC, Actavis LLC, AbbVie Inc., McKesson Corporation, Ortho-McNeil-Janssen Pharmaceutcals, Inc., Cardinal Health, Inc., Endo Health Solutions Inc., Actavis Pharma Inc, Knoll Pharmaceutical Company, a wholly-owned subsidiary of AbbVie Inc., Allergan plc f/k/a Actavis plc, Allergan Finance LLC, Purdue Pharma Inc. and Watson Laboratories, Inc. |
TXE/6:18-CV-00064 |
February 9, 2018 |
Judicial Panel on Multidistrict Litigation |
Robert W Schroeder |
Other |
Docket Report
This docket was last retrieved on April 17, 2018. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 30 ORDER VACATING CONDITIONAL TRANSFER ORDER (CTO-11) AND VACATING THE MAY 31, 2018 HEARING SESSION ORDER (( #1223 in MDL No. 2804, 29 in TXE/6:18-cv-00064), ( #1201 in MDL No. 2804, 28 in TXE/6:18-cv-00064), ( #759 in MDL No. 2804, 1 in TXE/6:18-cv-00064) )IT IS THEREFORE ORDERED that CTO-11 filed on FEBRUARY 16, 2018, is vacated insofar as it relates to this action.IT IS FURTHER ORDERED that the Hearing Session Order and the attached Schedule filed on APRIL 16, 2018, are VACATED insofar as they relate to this matter.Signed by Clerk of the Panel Jeffery N. Luthi on 4/17/2018. Associated Cases: MDL No. 2804, TXE/6:18-cv-00064 (CMD) |
Filing 29 SUPPLEMENTAL INFORMATION re: pldg. ( 759 in MDL No. 2804) Filed by Plaintiff County of Van Zandt. (Attachments: #1 Exhibit A - Order Remanding, #2 Other Proposed Order) Associated Cases: MDL No. 2804, TXE/6:18-cv-00064 (Carter, Amy) ADDED MDL LINK Modified on 4/17/2018 (CMD). |
Filing 28 HEARING ORDER re: pldg. (21 in DE/1:18-cv-00383, #1132 in MDL No. 2804), (30 in FLM/6:18-cv-00164, #880 in MDL No. 2804), (8 in KYE/3:18-cv-00010, #997 in MDL No. 2804), (23 in LAE/2:18-cv-02717, #1166 in MDL No. 2804), (27 in MD/1:18-cv-00519, #1005 in MDL No. 2804), ( #942 in MDL No. 2804, 25 in TXS/4:18-cv-00490), ( #1020 in MDL No. 2804, 10 in MT/6:18-cv-00033), ( #857 in MDL No. 2804, 26 in TXE/6:18-cv-00064), ( #1082 in MDL No. 2804, 13 in WVS/2:18-cv-00413), ( #1052 in MDL No. 2804, 22 in OKE/6:18-cv-00056), ( #979 in MDL No. 2804, 46 in TXS/4:18-cv-00490) in the following opposition(s) of Plaintiffs in 10 Actions - DE-1, FLM-1, KYE-1, LAE-1, MD-1, MT-1, OKE-1, TXE-1, TXS-1, WVS-1 - SECTION B (DESIGNATED FOR CONSIDERATION WITHOUT ORAL ARGUMENT) PANEL HEARING set for 5/31/2018 in Chicago, Illinois.Signed by Judge Sarah S. Vance, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 4/16/2018. Associated Cases: MDL No. 2804, DE/1:18-cv-00383, FLM/6:18-cv-00164, KYE/3:18-cv-00010, LAE/2:18-cv-02717, MD/1:18-cv-00519, MT/6:18-cv-00033, OKE/6:18-cv-00056, TXE/6:18-cv-00064, TXS/4:18-cv-00490, WVS/2:18-cv-00413 (RH) |
Filing 27 Joint RESPONSE IN OPPOSITION TO MOTION TO VACATE CTO (re: pldg. ( #857 in MDL No. 2804, 26 in TXE/6:18-cv-00064), ( #762 in MDL No. 2804, 3 in TXE/6:18-cv-00064) ) (CTO-11) Filed by Defendants AmerisourceBergen Corporation, #et al.Cardinal Health, Inc., McKesson Corporation #[Suppress List] (Attachments: #1 Exhibit County of Hopkins Notice of Removal, #2 Exhibit County of Van Zandt Notice of Removal, #3 Proof of Service) Associated Cases: MDL No. 2804, TXE/6:18-cv-00064 (Mainigi, Enu) |
Filing 26 MOTION TO VACATE CONDITIONAL TRANSFER ORDER WITH BRIEF IN SUPPORT (CTO-11) re: pldg. (4 in TXE/6:18-cv-00064), ( 762 in MDL No. 2804, 3 in TXE/6:18-cv-00064) Filed by Plaintiff County of Van Zandt (Attachments: #1 Memorandum, #2 Schedule of Actions, #3 Exhibit A, #4 Exhibit B, #5 Exhibit C, #6 Exhibit D, #7 Exhibit E, #8 Service List) Associated Cases: MDL No. 2804, TXE/6:18-cv-00064 (Carter, Amy) |
Filing 25 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent Endo International plc for Endo Health Solutions Inc., Endo Pharmaceuticals, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Stern, Jonathan) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTIES. |
Filing 24 NOTICE OF APPEARANCE FOR CTO-11 re: pldg. ( 759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Jonathan L. Stern on behalf of Defendants Endo Health Solutions, Inc., #et al.Endo Pharmaceuticals, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Stern, Jonathan) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTIES. |
Filing 23 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Lifland, Charles) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTY. |
Filing 22 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent No Parent Corp. for Johnson & Johnson. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Lifland, Charles) Modified on 3/7/2018 (TB). DELETED PARTY TYPE. |
Filing 21 NOTICE OF APPEARANCE FOR CTO-11 re: pldg. ( 759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Charles Coleman Lifland on behalf of Defendants Janssen Pharmaceutica, Inc., n/k/a Janssen Pharmaceuticals, Inc., #et al.Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Lifland, Charles) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTIES. |
Filing 20 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent Teva Pharmaceutical Industries, Ltd. for Actavis Pharma, Inc., Actavis, LLC, Watson Laboratories. (Attachments: #1 Supplement, #2 Schedule of Actions, #3 Proof of Service, #4 Service List) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Reed, Steven) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTIES. |
Filing 19 NOTICE OF APPEARANCE FOR CTO-11 re: pldg. ( 759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Steven A. Reed on behalf of Defendants Actavis LLC, #et al.Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., Watson Laboratories, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service, #3 Service List) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Reed, Steven) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTIES. |
Filing 18 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Non-Party/Financial Interest Walgreens Boots Alliance Holdings LLC for AmerisourceBergen Corporation. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Nicholas, Robert) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTY. |
Filing 17 NOTICE OF APPEARANCE FOR CTO-11 re: pldg. ( 759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Robert Arthur Nicholas on behalf of Defendants AmerisourceBergen Corporation(Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Nicholas, Robert) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTY. |
Filing 16 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent No Parent Corp. for McKesson Corporation. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Jessee, Russell) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTY. |
Filing 15 NOTICE OF APPEARANCE FOR CTO-11 re: pldg. ( 759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Russell David Jessee on behalf of Defendant McKesson Corporation (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Jessee, Russell) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTY. |
Filing 14 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent No Parent Corp. for Allergan PLC f/k/a Actavis PLC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Welch, Donna) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTIES. |
Filing 13 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent Allergan PLC for Allergan Finance LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Welch, Donna) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTIES. |
Filing 12 NOTICE OF APPEARANCE FOR CTO-11 re: pldg. ( 759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Donna Marie Welch on behalf of Defendants Allergan Finance LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc., #et al.Allergan PLC f/k/a Actavis PLC #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Welch, Donna) Modified on 3/7/2018 (TB). DELETED DUPLICATE PARTIES. |
Filing 11 NOTICE OF APPEARANCE FOR CTO-11 re: pldg. ( 759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Jeffrey Simon on behalf of Plaintiffs County of Van Zandt, Delta County of (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Carter, Amy) Modified on 3/6/2018 (TB). DELETED DUPLICATE ATTACHMENT DESCRIPTIONS ADDED JEFFREY SIMON TO DOCKET TEXT. |
Filing 10 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent No Parent Corp. for Cardinal Health, Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Mainigi, Enu) |
Filing 9 NOTICE OF APPEARANCE FOR CTO-11 re: pldg. ( #759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Enu Mainigi on behalf of Defendant Cardinal Health, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Mainigi, Enu) |
Filing 8 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent Pharmaceutical Research Associates, Inc. for The Purdue Frederick Company. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Cheffo, Mark) Modified on 2/28/2018 (TB). DELETED DUPLICATE PARTY. |
Filing 7 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent No Parent Corp. for Purdue Pharma Inc.(Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Cheffo, Mark) Modified on 2/28/2018 (TB). DELETED DUPLICATE PARTY. |
Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) -- Identifying Corporate Parent No Parent Corp. for Purdue Pharma, L.P. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Cheffo, Mark) Modified on 2/28/2018 (TB). DELETED DUPLICATE PARTY. |
Filing 5 NOTICE OF APPEARANCE FOR CTO-11 re: pldg. ( 759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Mark Steven Cheffo on behalf of Defendants Purdue Pharma Inc. #et al.Purdue Pharma, L.P., The Purdue Frederick Company #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Cheffo, Mark) Modified on 2/28/2018 (TB). DELETED DUPLICATE PARTIES. |
Filing 4 ***TEXT ONLY NOTICE***NOTICE OF FILED OPPOSITION TO CTO-11 AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #762 in MDL No. 2804, 3 in TXE/4:18-cv-00095, 3 in TXE/6:18-cv-00064) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 3/6/2018. Corporate Disclosure Statements due on or before 3/6/2018. Motion to Vacate with Brief in Support due on or before 3/6/2018. Responses due on or before 3/27/2018. #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel Jeffery N. Luthi on 2/20/2018. Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (TB) |
Filing 3 NOTICE OF OPPOSITION TO CONDITIONAL TRANSFER ORDER (CTO-11) - 2 action(s) - re: pldg. ( #759 in MDL No. 2804, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064) Filed by Plaintiffs County of Van Zandt, Delta County of Associated Cases: MDL No. 2804, TXE/4:18-cv-00095, TXE/6:18-cv-00064 (Carter, Amy) |
Filing 2 ***TEXT ONLY NOTICE***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-11) re: pldg. (1 in ALM/2:18-cv-00089, 1 in ALN/4:18-cv-00226, 1 in ALN/5:18-cv-00230, 2 in ALN/5:18-cv-00243, 1 in GAM/3:18-cv-00015, 1 in GAM/3:18-cv-00016, 1 in GAS/1:18-cv-00029, 1 in INS/1:18-cv-00378, #759 in MDL No. 2804, 1 in MN/0:18-cv-00350, 1 in NCE/7:18-cv-00021, 1 in NCW/3:18-cv-00071, 1 in ND/1:18-cv-00027, 1 in TXE/4:18-cv-00095, 1 in TXE/6:18-cv-00064, 1 in TXN/1:18-cv-00023, 1 in TXN/2:18-cv-00031, 1 in TXS/5:18-cv-00021, 1 in WAW/2:18-cv-00225, 1 in WVS/2:18-cv-00251, 1 in WVS/3:18-cv-00280, 1 in WVS/5:17-cv-04579) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 2/23/2018. Signed by Clerk of the Panel Jeffery N. Luthi on 2/16/2018. Associated Cases: MDL No. 2804, ALM/2:18-cv-00089, ALN/4:18-cv-00226, ALN/5:18-cv-00230, ALN/5:18-cv-00243, GAM/3:18-cv-00015, GAM/3:18-cv-00016, GAS/1:18-cv-00029, INS/1:18-cv-00378, MN/0:18-cv-00350, NCE/7:18-cv-00021, NCW/3:18-cv-00071, ND/1:18-cv-00027, TXE/4:18-cv-00095, TXE/6:18-cv-00064, TXN/1:18-cv-00023, TXN/2:18-cv-00031, TXS/5:18-cv-00021, WAW/2:18-cv-00225, WVS/2:18-cv-00251, WVS/3:18-cv-00280, WVS/5:17-cv-04579 (TB) |
Filing 1 CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-11) - 21 action(s) Signed by Clerk of the Panel Jeffery N. Luthi on 2/16/2018. Associated Cases: MDL No. 2804, ALM/2:18-cv-00089, ALN/4:18-cv-00226, ALN/5:18-cv-00230, ALN/5:18-cv-00243, GAM/3:18-cv-00015, GAM/3:18-cv-00016, GAS/1:18-cv-00029, INS/1:18-cv-00378, MN/0:18-cv-00350, NCE/7:18-cv-00021, NCW/3:18-cv-00071, ND/1:18-cv-00027, TXE/4:18-cv-00095, TXE/6:18-cv-00064, TXN/1:18-cv-00023, TXN/2:18-cv-00031, TXS/5:18-cv-00021, WAW/2:18-cv-00225, WVS/2:18-cv-00251, WVS/3:18-cv-00280, WVS/5:17-cv-04579 (TB) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.